Find the right professional pathways to aid in your weight loss with options like Ozempic in Gilbert, Arizona
GLP-1/GIP, GLP-1/glucagon, and even triple agonists are the dominant focus, though the spectrum extends to other mechanisms as wellamylin, GIP antagonism, NK2 receptor agonism, and more, said DiMarchi Looking further ahead, DiMarchi sees potential for oral therapies, including oral peptides
The SURMOUNT-1 trial published in the New England Journal of Medicine demonstrated remarkable results: participants achieved an average weight loss of 15% to 20.9% of their total body weight over 72 weeks, compared to just 3.1% in the placebo group
Regular check-ups, including blood tests and other assessments, can help catch potential problems early